In: Columbus Venture Partners
From seven to 435 workers in six years: the miracle of the virus cure factory
11/04/2024An advanced therapies company against lethal diseases, Viralgen, has propelled San Sebastian to become the city with the highest R&D weight…
Read MoreMultiverse raises $27M for quantum software targeting LLM leviathans
13/03/2024We’re still years away from seeing physical quantum computers break into the market with any scale and reliability, but don’t give…
Read More
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIaArthemiRTM Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)
28/02/2024ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, announced that the U.S….
Read More
Aleta Biotherapeutics and Cancer Research UK’s Centre for Drug Development Announce First Patient Dosed in ALETA-001 Phase 1/2 Clinical Trial in Patients with Relapsed/Refractory B-Cell Malignancies
22/02/2024Aleta Biotherapeutics (Aleta), a clinical stage, immuno-oncology company with a CAR T-Cell Engager (CTE) platform that enables cell cancer therapies to…
Read MoreVironova BioAnalytics is Acquired by Quatre Lab
29/11/2023Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry;... Read More
The Director of Quatre Lab Receives an Award for Her Brilliant Career
13/11/2023Patricia Muñoz, Doctor in Biomedical Research and Director of the affiliated company Quatre Lab, receives an award for her career in... Read More
ARTHEx Biotech in the 3rd Annual Needham Private Biotech Company Virtual Forum
11/10/2023ARTHEx Biotech to Participate in the 3rd Annual Needham Private Biotech Company Virtual 1x1 Forum Valencia, Spain, October 11, 2023 –... Read More
CVP BioSpain sponsor´s 2023, one of the Europe´s largest events
26/09/2023From September 26th to 28th, Barcelona, a hub of healthcare innovation in Europe, will host BIOSPAIN The vibrant city of Barcelona... Read More
Minoryx submits a marketing authorisation application for its drug leriglitazone for the treatment of X-ALD.
15/09/2022X-linked adrenoleukodystrophy (X-ALD) is a rare, neurodegenerative disease for which there is no treatment. Mataró, Barcelona, Spain, September 14, 2022 –... Read More
Columbus VP leads the new investment round of Integra Therapeutics with €1.5M
30/03/2022The biotechnology firm completes the seed round funding with a total of €6 million led last December by AdBio Partners, Invivo... Read More